1. Aisner J, Hansen HH (1981) Commentary: Current status of chemotherapy for non-small cell lung cancer. Cancer Treat Rep 65: 979–986
2. Anderson P, Spain R, Speer J (1984) Mitomycin-C (M), Cis-Platinum (P) and Vinblastine (V) infusion (M-PV) in combined modality therapy (CMT) of Stage III non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 3: 217
3. Beretta G, Clerici M, Labianca R et al. (1981) CAMP polychemotherapy in locally advanced unresectable and/or metastatic non-small cell carcinoma of the lung. Abstracts, UICC Conference on Clinical Oncology, Lausanne, Switzerland, p 20
4. Bitran JD, Desser RK, DeMeester T et al. (1978) Metastatic non-oat cell bronchogenic carcinoma: therapy with cyclophosphamide, doxorubicin, methotrexate and procarbazine (CAMP). J Am Med Assoc 240: 2743–2746
5. Bodey GP, Lagakos SW, Gutierrez AC (1977) Therapy of advanced squamous carcinoma of the lung. Cyclophosphamide versus “COMB”. Cancer 39: 1026–1031